Epidemiological, clinical, and economic burden of myocardial infarction patients in Iran during the COVID-19 pandemic

Background: To define changes in AMI case rates, patient demographics, cardiovascular comorbidities, treatment approaches, in-hospital outcomes, and the economic burden of COVID-19 during the pandemic. Methods: We conducted a multicenter, observational survey with selected hospitals from three medic...

Full description

Bibliographic Details
Main Authors: Hamid Pourasghari, Pirhossein Kolivand, Samad Azari, Peyman Saberian, Masoud Behzadifar, Negar Omidi, Shahrzad Salehbeigi, Behzad Raei, Soheila Rajaie, Nicola Luigi Bragazzi, Reza Golpira, Mohammd Rafie Khorgami, Mohammad Khani, Sara Montazerinamin, Farhad Lotfi, Masih Tajdini
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:International Journal of Cardiology: Heart & Vasculature
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352906723001197
_version_ 1797398581492056064
author Hamid Pourasghari
Pirhossein Kolivand
Samad Azari
Peyman Saberian
Masoud Behzadifar
Negar Omidi
Shahrzad Salehbeigi
Behzad Raei
Soheila Rajaie
Nicola Luigi Bragazzi
Reza Golpira
Mohammd Rafie Khorgami
Mohammad Khani
Sara Montazerinamin
Farhad Lotfi
Masih Tajdini
author_facet Hamid Pourasghari
Pirhossein Kolivand
Samad Azari
Peyman Saberian
Masoud Behzadifar
Negar Omidi
Shahrzad Salehbeigi
Behzad Raei
Soheila Rajaie
Nicola Luigi Bragazzi
Reza Golpira
Mohammd Rafie Khorgami
Mohammad Khani
Sara Montazerinamin
Farhad Lotfi
Masih Tajdini
author_sort Hamid Pourasghari
collection DOAJ
description Background: To define changes in AMI case rates, patient demographics, cardiovascular comorbidities, treatment approaches, in-hospital outcomes, and the economic burden of COVID-19 during the pandemic. Methods: We conducted a multicenter, observational survey with selected hospitals from three medical universities in Tehran city. A data collection tool consisting of three parts. The first part included socio-demographic information, and the second part included clinical information, major complications, and in-hospital mortality. Finally, the third part was related to the direct medical costs generated by AMI in COVID-19 and non-COVID-19 patients. The study cohort comprised 4,560 hospitalizations for AMI (2,935 for STEMI [64%] and 1,625 for NSTEMI [36%]). Results: Of those hospitalized for AMI, 1,864 (76.6 %) and 1,659 (78 %) were male before the COVID-19 outbreak and during the COVID-19 era, respectively. The length of stay (LOS), was significantly lower during the COVID-19 pandemic era (4.27 ± 3.63 vs 5.24 ± 5.17, p = 0.00). Results showed that there were no significant differences in terms of patient risk factors across periods. A total of 2,126 AMIs were registered during the COVID-19 era, with a 12.65 % reduction (95 % CI 1.5–25.1) compared with the equivalent time in 2019 (P = 0.179). The risk of in-hospital mortality rate for AMI patients increased from 4.9 % in 2019 to 7.0 % in the COVID-19 era (OR = 1.42; 95 % CI 1.11–1.82; P = 0.004). Major complications were registered in 9.7 % of cases in 2020, which is higher than the rate of 6.6 % reported in 2019 (OR = 1.46, 95 % CI 1.11–1.82; P = 0.000). Total costs in hospitalized AMI-COVID patients averaged $188 more than in AMI patients (P = 0.020). Conclusion: This cross-sectional study found important changes in AMI hospitalization rates, worse outcomes, and higher costs during the COVID-19 periods. Future studies are recommended to examine the long-term outcomes of hospitalized AMI patients during the COVID-19 era.
first_indexed 2024-03-09T01:27:33Z
format Article
id doaj.art-a63c47008ab44e6991d7e68001d1f403
institution Directory Open Access Journal
issn 2352-9067
language English
last_indexed 2024-03-09T01:27:33Z
publishDate 2023-12-01
publisher Elsevier
record_format Article
series International Journal of Cardiology: Heart & Vasculature
spelling doaj.art-a63c47008ab44e6991d7e68001d1f4032023-12-10T06:16:28ZengElsevierInternational Journal of Cardiology: Heart & Vasculature2352-90672023-12-0149101288Epidemiological, clinical, and economic burden of myocardial infarction patients in Iran during the COVID-19 pandemicHamid Pourasghari0Pirhossein Kolivand1Samad Azari2Peyman Saberian3Masoud Behzadifar4Negar Omidi5Shahrzad Salehbeigi6Behzad Raei7Soheila Rajaie8Nicola Luigi Bragazzi9Reza Golpira10Mohammd Rafie Khorgami11Mohammad Khani12Sara Montazerinamin13Farhad Lotfi14Masih Tajdini15Hospital Management Research Center, Health Management Research Institute, Iran University of Medical Sciences, Tehran, IranDepartment of Health Economics, Faculty of Medicine, Shahed University, Tehran, IranHospital Management Research Center, Health Management Research Institute, Iran University of Medical Sciences, Tehran, Iran; Corresponding author at: Iran University of Medical Sciences, No. 6, Rashid Yasemi Street, Valie-Asr Avenue, Tehran 1996713883, Iran.Department of Anesthesiology, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, IranSocial Determinants of Health Research Center, Lorestan University of Medical Sciences, Khorramabad, IranTehran Heart Center, Cardiovascular Disease Research Institute, Tehran University of Medical Sciences, Tehran, IranTehran Heart Center, Cardiovascular Disease Research Institute, Tehran University of Medical Sciences, Tehran, IranRazi Educational and Therapeutic Center, Tabriz University of Medical Science, Tabriz, IranResearch Center for Emergency and Disaster Resilience, Red Crescent Society of the Islamic Republic of Iran, Tehran, IranHospital Management Research Center, Health Management Research Institute, Iran University of Medical Sciences, Tehran, IranRajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, IranRajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, IranCardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IranTehran Heart Center, Cardiovascular Disease Research Institute, Tehran University of Medical Sciences, Tehran, IranNational Center for Health Insurance Research, Tehran, IranTehran Heart Center, Cardiovascular Disease Research Institute, Tehran University of Medical Sciences, Tehran, IranBackground: To define changes in AMI case rates, patient demographics, cardiovascular comorbidities, treatment approaches, in-hospital outcomes, and the economic burden of COVID-19 during the pandemic. Methods: We conducted a multicenter, observational survey with selected hospitals from three medical universities in Tehran city. A data collection tool consisting of three parts. The first part included socio-demographic information, and the second part included clinical information, major complications, and in-hospital mortality. Finally, the third part was related to the direct medical costs generated by AMI in COVID-19 and non-COVID-19 patients. The study cohort comprised 4,560 hospitalizations for AMI (2,935 for STEMI [64%] and 1,625 for NSTEMI [36%]). Results: Of those hospitalized for AMI, 1,864 (76.6 %) and 1,659 (78 %) were male before the COVID-19 outbreak and during the COVID-19 era, respectively. The length of stay (LOS), was significantly lower during the COVID-19 pandemic era (4.27 ± 3.63 vs 5.24 ± 5.17, p = 0.00). Results showed that there were no significant differences in terms of patient risk factors across periods. A total of 2,126 AMIs were registered during the COVID-19 era, with a 12.65 % reduction (95 % CI 1.5–25.1) compared with the equivalent time in 2019 (P = 0.179). The risk of in-hospital mortality rate for AMI patients increased from 4.9 % in 2019 to 7.0 % in the COVID-19 era (OR = 1.42; 95 % CI 1.11–1.82; P = 0.004). Major complications were registered in 9.7 % of cases in 2020, which is higher than the rate of 6.6 % reported in 2019 (OR = 1.46, 95 % CI 1.11–1.82; P = 0.000). Total costs in hospitalized AMI-COVID patients averaged $188 more than in AMI patients (P = 0.020). Conclusion: This cross-sectional study found important changes in AMI hospitalization rates, worse outcomes, and higher costs during the COVID-19 periods. Future studies are recommended to examine the long-term outcomes of hospitalized AMI patients during the COVID-19 era.http://www.sciencedirect.com/science/article/pii/S2352906723001197COVID-19Acute myocardial infarctionCardiac care unitsEconomic burden
spellingShingle Hamid Pourasghari
Pirhossein Kolivand
Samad Azari
Peyman Saberian
Masoud Behzadifar
Negar Omidi
Shahrzad Salehbeigi
Behzad Raei
Soheila Rajaie
Nicola Luigi Bragazzi
Reza Golpira
Mohammd Rafie Khorgami
Mohammad Khani
Sara Montazerinamin
Farhad Lotfi
Masih Tajdini
Epidemiological, clinical, and economic burden of myocardial infarction patients in Iran during the COVID-19 pandemic
International Journal of Cardiology: Heart & Vasculature
COVID-19
Acute myocardial infarction
Cardiac care units
Economic burden
title Epidemiological, clinical, and economic burden of myocardial infarction patients in Iran during the COVID-19 pandemic
title_full Epidemiological, clinical, and economic burden of myocardial infarction patients in Iran during the COVID-19 pandemic
title_fullStr Epidemiological, clinical, and economic burden of myocardial infarction patients in Iran during the COVID-19 pandemic
title_full_unstemmed Epidemiological, clinical, and economic burden of myocardial infarction patients in Iran during the COVID-19 pandemic
title_short Epidemiological, clinical, and economic burden of myocardial infarction patients in Iran during the COVID-19 pandemic
title_sort epidemiological clinical and economic burden of myocardial infarction patients in iran during the covid 19 pandemic
topic COVID-19
Acute myocardial infarction
Cardiac care units
Economic burden
url http://www.sciencedirect.com/science/article/pii/S2352906723001197
work_keys_str_mv AT hamidpourasghari epidemiologicalclinicalandeconomicburdenofmyocardialinfarctionpatientsiniranduringthecovid19pandemic
AT pirhosseinkolivand epidemiologicalclinicalandeconomicburdenofmyocardialinfarctionpatientsiniranduringthecovid19pandemic
AT samadazari epidemiologicalclinicalandeconomicburdenofmyocardialinfarctionpatientsiniranduringthecovid19pandemic
AT peymansaberian epidemiologicalclinicalandeconomicburdenofmyocardialinfarctionpatientsiniranduringthecovid19pandemic
AT masoudbehzadifar epidemiologicalclinicalandeconomicburdenofmyocardialinfarctionpatientsiniranduringthecovid19pandemic
AT negaromidi epidemiologicalclinicalandeconomicburdenofmyocardialinfarctionpatientsiniranduringthecovid19pandemic
AT shahrzadsalehbeigi epidemiologicalclinicalandeconomicburdenofmyocardialinfarctionpatientsiniranduringthecovid19pandemic
AT behzadraei epidemiologicalclinicalandeconomicburdenofmyocardialinfarctionpatientsiniranduringthecovid19pandemic
AT soheilarajaie epidemiologicalclinicalandeconomicburdenofmyocardialinfarctionpatientsiniranduringthecovid19pandemic
AT nicolaluigibragazzi epidemiologicalclinicalandeconomicburdenofmyocardialinfarctionpatientsiniranduringthecovid19pandemic
AT rezagolpira epidemiologicalclinicalandeconomicburdenofmyocardialinfarctionpatientsiniranduringthecovid19pandemic
AT mohammdrafiekhorgami epidemiologicalclinicalandeconomicburdenofmyocardialinfarctionpatientsiniranduringthecovid19pandemic
AT mohammadkhani epidemiologicalclinicalandeconomicburdenofmyocardialinfarctionpatientsiniranduringthecovid19pandemic
AT saramontazerinamin epidemiologicalclinicalandeconomicburdenofmyocardialinfarctionpatientsiniranduringthecovid19pandemic
AT farhadlotfi epidemiologicalclinicalandeconomicburdenofmyocardialinfarctionpatientsiniranduringthecovid19pandemic
AT masihtajdini epidemiologicalclinicalandeconomicburdenofmyocardialinfarctionpatientsiniranduringthecovid19pandemic